Microsatellite frameshift variants in SGO1 of gastric cancer are not always associated with MSI status
暂无分享,去创建一个
H. Sugimura | T. Ohta | H. Miyajima | S. Osawa | T. Furuta | M. Yamade | M. Maekawa | Y. Hamaya | T. Taniguchi | K. Sugimoto | S. Tani | M. Iwaizumi | S. Baba | Satoshi Suzuki | T. Sugiyama | Shinya Tani
[1] A. Bass,et al. Genomics and Targeted Therapies in Gastroesophageal Adenocarcinoma. , 2019, Cancer discovery.
[2] D M Parkin,et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods , 2018, International journal of cancer.
[3] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[4] A. Barzi,et al. Outlooks on Epstein-Barr virus associated gastric cancer. , 2018, Cancer treatment reviews.
[5] Gad Getz,et al. Analysis of somatic microsatellite indels identifies driver events in human tumors , 2017, Nature Biotechnology.
[6] Kazuhiro Yoshida,et al. Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial. , 2017, The lancet. Gastroenterology & hepatology.
[7] Sheng-fang Jiang,et al. Impact of Age on Clinicopathological Features and Survival of Patients with Noncardia Gastric Adenocarcinoma , 2014, Journal of gastric cancer.
[8] Naotoshi Sugimoto,et al. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. , 2014, The Lancet. Oncology.
[9] Steven J. M. Jones,et al. Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.
[10] K. Muro,et al. Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer , 2014, Cancer science.
[11] Takashi Takahashi,et al. SGOL1 variant B induces abnormal mitosis and resistance to taxane in non-small cell lung cancers , 2013, Scientific Reports.
[12] N. Yoo,et al. Frameshift mutations of chromosome cohesion-related genes SGOL1 and PDS5B in gastric and colorectal cancers with high microsatellite instability. , 2013, Human pathology.
[13] 喜彦 前原,et al. 【消化器癌とサイトメトリー】 消化器癌におけるDNA aneuploidyの意義 , 2012 .
[14] C. Rao,et al. Haploinsufficiency of SGO1 results in deregulated centrosome dynamics, enhanced chromosomal instability and colon tumorigenesis , 2012, Cell cycle.
[15] H. Sugimura,et al. A novel tumor-derived SGOL1 variant causes abnormal mitosis and unstable chromatid cohesion , 2011, Oncogene.
[16] Silvia Polakova,et al. Merotelic kinetochore attachment: causes and effects , 2011, Trends in cell biology.
[17] Yoshinori Watanabe,et al. Phosphorylation of the CPC by Cdk1 promotes chromosome bi-orientation , 2010, Nature.
[18] S. Noh,et al. Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea. , 2010, World journal of gastroenterology.
[19] Yoshinori Watanabe,et al. Phosphorylation of H2A by Bub1 Prevents Chromosomal Instability Through Localizing Shugoshin , 2010, Science.
[20] W. Earnshaw,et al. Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins , 2009, Current opinion in cell biology.
[21] D. Cleveland,et al. Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis , 2009, Nature Reviews Molecular Cell Biology.
[22] David Pellman,et al. A Mechanism Linking Extra Centrosomes to Chromosomal Instability , 2009, Nature.
[23] F. Merchant,et al. Overexpression and Mislocalization of the Chromosomal Segregation Protein Separase in Multiple Human Cancers , 2009, Clinical Cancer Research.
[24] M. Shimura,et al. Heterochromatin links to centromeric protection by recruiting shugoshin , 2008, Nature.
[25] F. Kittrell,et al. Overexpression of Separase induces aneuploidy and mammary tumorigenesis , 2008, Proceedings of the National Academy of Sciences.
[26] H. Sugimura,et al. Human Sgo1 downregulation leads to chromosomal instability in colorectal cancer , 2008, Gut.
[27] G. Parmigiani,et al. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers , 2008, Proceedings of the National Academy of Sciences.
[28] J. Brenton,et al. Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. , 2007, Cancer cell.
[29] Tohru Natsume,et al. Shugoshin collaborates with protein phosphatase 2A to protect cohesin , 2006, Nature.
[30] Karl Mechtler,et al. Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I , 2006, Nature.
[31] Lior Pachter,et al. Reference based annotation with GeneMapper , 2006, Genome Biology.
[32] C. Swanton,et al. Chromosomal Instability, Colorectal Cancer and Taxane Resistance , 2006, Cell cycle.
[33] Kim Nasmyth,et al. Shugoshin Prevents Dissociation of Cohesin from Centromeres During Mitosis in Vertebrate Cells , 2005, PLoS biology.
[34] T. Kitajima,et al. Human Bub1 Defines the Persistent Cohesion Site along the Mitotic Chromosome by Affecting Shugoshin Localization , 2005, Current Biology.
[35] N. Rahman,et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B , 2004, Nature Genetics.
[36] J. Yokota,et al. A novel splice-site variant of the base excision repair gene MYH is associated with production of an aberrant mRNA transcript encoding a truncated MYH protein not localized in the nucleus. , 2004, Carcinogenesis.
[37] T. Mitchison,et al. Vertebrate Shugoshin Links Sister Centromere Cohesion and Kinetochore Microtubule Stability in Mitosis , 2004, Cell.
[38] H. Saya,et al. Dependence of Paclitaxel Sensitivity on a Functional Spindle Assembly Checkpoint , 2004, Cancer Research.
[39] T. Kitajima,et al. The conserved kinetochore protein shugoshin protects centromeric cohesion during meiosis , 2004, Nature.
[40] H. Grabsch,et al. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer—association with tumour cell proliferation , 2003, The Journal of pathology.
[41] S. Tsao,et al. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. , 2002, Cancer research.
[42] H. Ellegren. Microsatellite mutations in the germline: implications for evolutionary inference. , 2000, Trends in genetics : TIG.
[43] S Srivastava,et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.
[44] N. Lawrence,et al. Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle , 1998, Medicinal research reviews.
[45] K. Kinzler,et al. Genetic instability in colorectal cancers , 1997, Nature.
[46] P. Laurén,et al. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.
[47] H. Sugimura,et al. Suppression of hydroxyurea-induced centrosome amplification by NORE1A and down-regulation of NORE1A mRNA expression in non-small cell lung carcinoma. , 2011, Lung cancer.
[48] F. Bosman,et al. WHO Classification of Tumours of the Digestive System , 2010 .
[49] T. Fojo,et al. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. , 1997, Cancer research.